VANCOMYCIN HYDROCHLORIDE | ||||
CAS NO.: | 1404-93-9 | |||
Chemical Formula: | C66H75Cl2N9O24•HCl | |||
Molecular Weight: | 1485.7100 | |||
DMF&GMP status: | Please contact us for more details. | Description: |
VANCOMYCIN HYDROCHLORIDE API Supplier | CAS 1404-93-9 | Genegobio | Vancomycin is an antibiotic. When taken by mouth it fights bacteria in the intestines.Vancomycin is used to treat an infection of the intestines caused by Clostridium difficile, which can cause watery or bloody diarrhea. It is also used to treat staph infections that can cause inflammation of the colon and small intestines.Oral vancomycin works only in the intestines. This medicine is not normally absorbed into the body and will not treat other types of infection. An injection form of this medication is available to treat serious infections in other parts of the body.
|
|
Approvals | ||||
Active Ingredient | Dosage Form; Route | Strength | Proprietary Name | Applicant |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 125MG BASE | VANCOCIN HYDROCHLORIDE | ANI PHARMS INC |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 250MG BASE | VANCOCIN HYDROCHLORIDE | ANI PHARMS INC |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 125MG BASE | VANCOMYCIN HYDROCHLORIDE | AKORN |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 250MG BASE | VANCOMYCIN HYDROCHLORIDE | AKORN |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 125MG BASE | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 250MG BASE | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 125MG BASE | VANCOMYCIN HYDROCHLORIDE | LUPIN LTD |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 250MG BASE | VANCOMYCIN HYDROCHLORIDE | LUPIN LTD |
VANCOMYCIN HYDROCHLORIDE | CAPSULE; ORAL | EQ 125MG BASE | VANCOMYCIN HYDROCHLORIDE | STRIDES PHARMA |
Patent Data | ||||
Patent No. | Patent Expiration | Drug Substance Claim | Drug Product Claim | Patent Use Code |
Exclusive Data | ||||
Exclusivity Code | Exclusivity Expiration | |||